Acute lymphoblastic leukaemia

European Journal of Cancer Part A

Volumn 33, Issue 1, 1997, Pages 85-90

  Lilleyman, J S ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINASE; CORTICOSTEROID; DEXAMETHASONE; PREDNISOLONE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; CHILDHOOD LEUKEMIA; HUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0031038492     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(96)00428-5     Document Type: Article

References (66)

1. 1. Robison LL, Ross JA. Epidemiology of leukaemias and lymphomas in childhood. Balliere's Clin Paediat 1995, 3, 639-657.
2. 2. Court-Brown WM, Doll R. Leukaemia in childhood and young adult life. Br Med J 1961, 1, 1981-1998.
3. 3. Gardner MJ, Snee MP, Hall AJ, et al. Results of case-control study of leukaemia and lymphoma among people near Sellafield nuclear plant in West Cumbria. Br Med J 1990, 300, 423-429.
4. 4. Kinlen LJ. Epidemiological evidence for an infective basis in childhood leukaemia. Br J Cancer 1995, 71, 1-5.
5. 5. Greaves MF, Alexander FE. An infectious etiology for common acute lymphoblastic leukemia in childhood? Leukemia 1993, 7, 349-360.
6. 6. Shurtleff S, Buijs A, Behm F, Rubnitz J, et al. TEL/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis. Leukemia 1995, 9, 1985-1989.
7. 7. Stewart A, Kneale GW. Radiation dose effects in relation to obstetric X-rays and childhood cancers. Lancet 1970, i, 1185-1188.
8. 8. Cartwright R. Low frequency alternating electromagnetic fields and leukaemia: the saga so far. Br J Cancer 1989, 60, 649-651.
9. 9. Bennett JM, Catovsky D, Daniel MT, et al. The morphological classification of acute lymphoblastic leukaemia: concordance among observers and clinical correlations. Br J Haematol 1981, 47, 553-561.
10. 10. Lilleyman J, Hann I, Stevens R, et al. Cytomorphology of childhood lymphoblastic leukaemia: a prospective study of 2000 patients. Br J Haematol 1992, 81, 52-57.
11. 11. Lilleyman JS, Hann IM, Stevens RF, Richards SM, Eden OB. Blast cell vacuoles in childhood lymphoblastic leukaemia. Br J Haematol 1988, 70, 183-186.
12. 12. Lilleyman JS, Scott CS. PAS and acid phosphatase cytochemistry in acute lymphoblastic leukaemia. In Scott CS, ed. Leukaemia Cytochemistry: Principles and Practice. Chichester, Ellis Horwood, 1989, 103-120.
13. 13. Pui C-H, Behm FG, Crist WM. Clinical and biological relevance of immunologic marker studies in childhood acute lymphoblastic leukemia. Blood 1993, 82, 343-362.
14. 14. Pui C-H, Behm FG, Singh B, et al. Myeloid-associated antigen expression lacks prognostic value in childhood acute lymphoblastic leukemia treated with intensive multiagent chemotherapy. Blood 1990, 75, 198-202.
15. 15. Wiersma SR, Ortega J, Sobel E, Weinberg KI. Clinical importance of myeloid-antigen expression in acute lymphoblastic leukemia of childhood. N Engl J Med 1991, 324, 800-808.
16. 16. Fink FM, Killer U, Mayer H, et al. Prognostic significance of myeloid-associated antigen expression on blast cells in children with acute lymphoblastic leukemia. The Austrian Pediatric Oncology Group. Med Pediatr Oncol 1993, 21, 340-346.
17. 17. Ludwig W-D, Raghavachar A, Thiel E. Immunophenotypic classification of acute lymphoblastic leukaemia. Balliere's Clin Haematol 1994, 7, 235-262.
18. 18. Howard MR, Thomas L, Reid MM. Variable detection of myeloid antigens in childhood acute lymphoblastic leukaemia. J Clin Pathol 1994, 47, 1006-1009.
19. 19. Trueworthy R, Shuster J, Look T, et al. Ploidy of lymphoblasts is the strongest predictor of treatment outcome in B-progenitor cell acute lymphoblastic leukaemia of childhood: a Pediatric Oncology Group Study. J Clin Oncol 1992, 10, 606-613.
20. 20. Pui C-H, Raimondi SC, Dodge RK, et al. Prognostic importance of structural chromosome abnormalities in children with hyperdiploid (greater than 50 chromosomes) acute lymphoblastic leukaemia. Blood 1989, 73, 1963-1967.
21. 21. Raimondi SC. Current status of cytogenetic research in childhood lymphoblastic leukaemia. Blood 1993, 81, 2237-2251.
22. 22. Beyermann B, Agthe AG, Adams HP, et al. Clinical features and outcome of children with first marrow relapse of acute lymphoblastic leukemia expressing BCR-ABL fusion transcripts. BFM Relapse Study Group. Blood 1996, 87, 1532-1538.
23. 23. Chen C-S, Sorensen PHB, Domer PH, et al. Molecular rearrangements on chromosome 11q23 predominate in infant acute lymphoblastic leukemia and are associated with specific biologic variables and poor outcome. Blood 1993, 81, 2386-2393.
24. 24. Romana SP, Poirel M, Leconiat M, et al. High frequency of t(12;21) in childhood B-lineage acute lymphoblastic leukemia. Blood 1995, 86, 4263-4269.
25. 25. Burchenal JH, Karnofsky DA, Kingsley-Pillers EM, et al. The effects of the folic acid antagonists and 2,6 diaminopurine on neoplastic disease. With special reference to acute leukemia. Cancer 1951, 4, 549-569.
26. 26. Zippin C, Cutler SJ, Reeves WJ, Lum D. Variation in survival among patients with acute lymphocytic leukemia. Blood 1971, 37, 59-72.
27. 27. Pinkel D. Selecting treatment for children with acute lymphoblastic leukemia. J Clin Oncol 1996, 14, 4-6.
28. 28. Smith M, Arthur D, Camitta B, et al. Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia. J Clin Oncol 1996, 14, 18-24.
29. 29. Reiter A, Schrappe M, Ludwig WD, et al. Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86. Blood 1994, 84, 3122-3133.
30. 30. Miller DR, Coccia PF, Bleyer A, et al. Early response to induction therapy as a predictor or disease-free survival and late recurrence of childhood acute lymphoblastic leukemia: a report from the Children's Cancer Study Group. J Clin Oncol 1989, 7, 1807-1815.
31. 31. Chessells J, Bailey C, Richards S. Intensification of treatment and survival in all children with lymphoblastic leukaemia: results of UK Medical Research Council Trial UKALL X. Lancet 1994, 345, 143-148.
32. 32. Steinherz PG, Gaynon PS, Breneman JC, et al. Cytoreduction and prognosis in acute lymphoblastic leukemia - the importance of early marrow response: report from the Children's Cancer Group. J Clin Oncol 1996, 14, 389-398.
33. 33. Mahmoud H, Rivera G, Hancock M, et al. Low leukocyte counts with blast cells in cerebrospinal fluid of children with newly diagnosed acute lymphoblastic leukemia. N Engl J Med 1993, 329, 314-319.
34. 34. Lauer S, Shuster J, Kirchner P, et al. Prognostic significance of cerebrospinal fluid (CSF) lymphoblasts (LB) at diagnosis (dx) in children with acute lymphoblastic leukemia (ALL). Proc Am Soc Clin Oncol 1994, 13, 317.
35. 35. Gilchrist G, Tubergen D, Sather H, et al. Low numbers of CSF blasts at diagnosis do not predict for the development of CNS leukemia in children with intermediate-risk acute lymphoblastic leukemia. A Children's Cancer Group Study. J Clin Oncol 1994, 12, 2594-2600.
36. 36. Riehm H, Gadner H, Henze G, et al. Results and significance of six randomized trials in four consecutive ALL-BFM studies. Hematol Blood Transfusion 1990, 33, 439-450.
37. 37. Rivera GK, Pinkel D, Simone JV, Hancock ML, Crist WM. Treatment of acute lymphoblastic leukemia 30 years' experience at St Jude Children's Research Hospital. N Engl J Med 1993, 329, 1289-1295.
38. 38. Tubergen DG, Gilchrist GS, O'Brien RT, et al. Improved outcome with delayed intensification for children with acute lymphoblastic leukemia and intermediate presenting features: a Children's Cancer Group phase III trial. J Clin Oncol 1993, 11, 527-537.
39. 39. Veerman AJ, Hahlen K, Kamps WA, et al. High cure rate with a moderately intensive treatment regimen in non-high-risk childhood acute lymphoblastic leukemia. Results of protocol ALL VI from the Dutch Childhood Leukemia Study Group. J Clin Oncol 1996, 14, 911-918.
40. 40. Pinkel D. Five year follow-up of "total therapy" of childhood lymphocytic leukemia. JAMA 1971, 216, 648-652.
41. 41. Riehm H, Gadner H, Henze G, et al. Acute lymphoblastic leukemia: treatment results in three BFM studies (1970-1981). In Murphy S, Gilbert JR. Leukemia Research: Advances in Cell Biology and Treatment. Oxford, Elsevier, 1983, 251-260.
42. 42. Camitta B, Leventhal B, Lauer S, et al. Intermediate-dose intravenous methotrexate and mercaptopurine therapy for non-T, non-B acute lymphocytic leukemia of childhood: a Pediatric Oncology Group study. J Clin Oncol 1989, 7, 1539-1544.
43. 43. Asselin BL, Whitin JC, Coppola DJ., et al. Comparative pharmacokinetic studies of three asparaginase preparations. J Clin Oncol 1993, 11, 1780-1786.
44. 44. Eden OB, Shaw MP, Lilleyman JS, Richards S. Non-randomized study comparing toxicity of Escherichia coli and Erwinia asparaginase in children with leukaemia. Med Ped Oncol 1990, 18, 497-502.
45. 45. Littman P, Coccia P, Bleyer WA, et al. Central nervous system (CNS) prophylaxis in children with low risk acute lymphoblastic leukemia (ALL). Int J Radiat Oncol Biol Phys 1987, 13, 1443-1449.
46. 46. Pullen J, Boyett J, Shuster J, et al. Extended triple intrathecal chemotherapy trial for prevention of CNS relapse in good risk and poor risk patients with B-progenitor acute lymphoblastic leukemia. A Pediatric Oncology Group study. J Clin Oncol 1993, 11, 839-849.
47. 47. Lennard L, Lilleyman JS, Van Loon J, Weinshilboum RM. Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukaemia. Lancet 1990, 336, 225-229.
48. 48. Lilleyman JS, Lennard L. Non-compliance with oral chemotherapy in childhood leukaemia - an overlooked prognostic factor. Br Med J, 1996, 313, 1219-1220.
49. 49. Viana MB, Murao M, Ramos G, et al. Malnutrition as a prognostic factor in lymphoblastic leukemia: a multivariate analysis. Arch Dis Child 1994, 71, 304-310.
50. 50. Walters TR, Bushmore M, Simone J, et al. Poor prognosis in negro children with acute lymphocytic leukemia. Cancer 1972, 29, 210-214.
51. 51. Lennard L, Davies HA, Lilleyman JS. Is 6-thioguanine more appropriate than 6-mercaptopurine for children with acute lymphoblastic leukaemia? Br J Cancer 1993, 68, 186-190.
52. 52. Chessells JM, Bailey C, Wheeler K, Richards SM. Bone marrow transplantation for high-risk childhood lymphoblastic leukaemia in first remission: experience in MRC UKALL X. Lancet 1992, 340, 565-568.
53. 53. Butturini A, Rivera GK, Borlin MM, Gale RP. Which treatment for childhood acute lymphoblastic leukaemia in second remission? Lancet 1987, i, 429-432.
54. 54. Casper J, Camitta B, Truitt R, et al. Unrelated bone marrow donor transplants for children with leukemia or mycloysplasia. Blood 1995, 85, 2354-2363.
55. 55. Oakhill A, Pamphilon DH, Potter MN, et al. Unrelated donor bone marrow transplantation for children with relapsed acute lymphoblastic leukaemia in second complete remission. Br J Haematol 1996, 94, 574-578.
56. 56. Wagner JE KN, Steinbuch M, Broxmer HE, Gluckman E. Allogeneic sibling umbilical cord blood transplantation in children with malignant and non-malignant disease. Lancet 1995, 346, 214-219.
57. 57. Kurtzberg J, Laughlin M, Graham ML, et al. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl J Med 1996, 335, 157-166.
58. 58. Silberstein L, Jefferies LC. Placental blood banking - a new frontier in transfusion medicine. N Engl J Med 1996, 335, 199-201.
59. 59. Hawkins MM, Draper GJ, Kingston JE. Incidence of second primary tumours among childhood cancer survivors. Br J Cancer 1987, 56, 339-347.
60. 60. Neglia JP, Meadows AT, Robison LL, et al. Second neoplasms after acute lymphoblastic leukaemia in childhood. N Engl J Med 1991, 325, 1330-1336.
61. 61. Pui C-H, Ribeiro RC, Hancock ML, et al. Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia. N Engl J Med 1991, 325, 1682-1687.
62. 62. Hale JP, Lewis IJ. Anthracyclines: cardiotoxicity and its prevention. Arch Dis Childh 1994, 71, 457-462.
63. 63. Schell MJ, Ochs JJ, Schriock EA, Carter M. A method for predicting adult height and obesity in long term survivors of childhood acute lymphoblastic leukemia. J Clin Oncol 1992, 10, 128-133.
64. 64. Jenney M, Kissen G. Late effects following treatment of childhood leukaemia and lymphoma. Balliere's Clin Paediat 1995, 3, 715-733.
65. 65. Sklar C, Mertens A, Walter A, et al. Final height after treatment for childhood acute lymphoblastic leukemia: comparison of no cranial irradiation with 1800 and 2400 centigrays of cranial irradiation. J Pediatr 1993, 123, 59-64.
66. 66. Wallace WHB, Shalet SM, Lendon M. Morris-Jones PH. Male fertility in long term survivors of acute lymphoblastic leukemia of childhood. Int J Androl 1991, 14, 312-319.